AIM ImmunoTech (AIM) Shares Outstanding (2018 - 2025)
Historic Shares Outstanding for ImmunoTech (AIM) over the last 11 years, with Q3 2025 value amounting to $2.8 million.
- ImmunoTech's Shares Outstanding rose 37115.37% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 37115.37%. This contributed to the annual value of $65.5 million for FY2024, which is 1324480.32% up from last year.
- Per ImmunoTech's latest filing, its Shares Outstanding stood at $2.8 million for Q3 2025, which was up 37115.37% from $764188.0 recorded in Q2 2025.
- ImmunoTech's Shares Outstanding's 5-year high stood at $48.8 million during Q3 2023, with a 5-year trough of $491025.0 in Q4 2023.
- Moreover, its 3-year median value for Shares Outstanding was $722900.0 (2025), whereas its average is $13.9 million.
- Per our database at Business Quant, ImmunoTech's Shares Outstanding tumbled by 9896.19% in 2024 and then soared by 37115.37% in 2025.
- Quarter analysis of 3 years shows ImmunoTech's Shares Outstanding stood at $491025.0 in 2023, then skyrocketed by 33.45% to $655263.0 in 2024, then soared by 321.84% to $2.8 million in 2025.
- Its Shares Outstanding stands at $2.8 million for Q3 2025, versus $764188.0 for Q2 2025 and $722900.0 for Q1 2025.